These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 26315451)

  • 41. Fibromyalgia in Italian patients with primary Sjögren's syndrome.
    Ostuni P; Botsios C; Sfriso P; Punzi L; Chieco-Bianchi F; Semerano L; Grava C; Todesco S
    Joint Bone Spine; 2002 Jan; 69(1):51-7. PubMed ID: 11858357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcultural adaptation of the "EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI)" into Brazilian Portuguese.
    Serrano EV; Valim V; Miyamoto ST; Giovelli RA; Paganotti MA; Cadê NV
    Rev Bras Reumatol; 2013; 53(6):483-93. PubMed ID: 24477727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A lower prevalence of malignant lymphoma in Sjögren's syndrome patients: A cross-sectional study.
    Saleh W; Elashry MM; Winn N; Mona M; Katz J; Cha S
    Oral Dis; 2023 Nov; 29(8):3313-3324. PubMed ID: 36369668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The efficacy and mechanism for action of iguratimod in primary Sjögren's syndrome patients.
    Jiang W; Zhang L; Zhao Y; He X; Hu C; Liu Y
    Int Ophthalmol; 2020 Nov; 40(11):3059-3065. PubMed ID: 32607949
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial.
    Cornec D; Devauchelle-Pensec V; Mariette X; Jousse-Joulin S; Berthelot JM; Perdriger A; Puéchal X; Le Guern V; Sibilia J; Gottenberg JE; Chiche L; Hachulla E; Yves Hatron P; Goeb V; Hayem G; Morel J; Zarnitsky C; Dubost JJ; Saliou P; Pers JO; Seror R; Saraux A
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):528-535. PubMed ID: 27390310
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI).
    Seror R; Theander E; Brun JG; Ramos-Casals M; Valim V; Dörner T; Bootsma H; Tzioufas A; Solans-Laqué R; Mandl T; Gottenberg JE; Hachulla E; Sivils KL; Ng WF; Fauchais AL; Bombardieri S; Valesini G; Bartoloni E; Saraux A; Tomsic M; Sumida T; Nishiyama S; Caporali R; Kruize AA; Vollenweider C; Ravaud P; Vitali C; Mariette X; Bowman SJ;
    Ann Rheum Dis; 2015 May; 74(5):859-66. PubMed ID: 24442883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary Sjögren's syndrome: Longitudinal real-world, observational data on health-related quality of life.
    Tarn J; Lendrem D; McMeekin P; Lendrem C; Hargreaves B; Ng WF
    J Intern Med; 2022 Jun; 291(6):849-855. PubMed ID: 35018685
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome.
    Seror R; Ravaud P; Mariette X; Bootsma H; Theander E; Hansen A; Ramos-Casals M; Dörner T; Bombardieri S; Hachulla E; Brun JG; Kruize AA; Praprotnik S; Tomsic M; Gottenberg JE; Devauchelle V; Devita S; Vollenweider C; Mandl T; Tzioufas A; Carsons S; Saraux A; Sutcliffe N; Vitali C; Bowman SJ;
    Ann Rheum Dis; 2011 Jun; 70(6):968-72. PubMed ID: 21345815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sjogren's syndrome.
    Newton JL; Frith J; Powell D; Hackett K; Wilton K; Bowman S; Price E; Pease C; Andrews J; Emery P; Hunter J; Gupta M; Vadivelu S; Giles I; Isenberg D; Lanyon P; Jones A; Regan M; Cooper A; Moots R; Sutcliffe N; Bombardieri M; Pitzalis C; McLaren J; Young-Min S; Dasgupta B; Griffiths B; Lendrem D; Mitchell S; Ng WF;
    Ann Rheum Dis; 2012 Dec; 71(12):1973-9. PubMed ID: 22562982
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peripheral neuropathy and health-related quality of life in patients with primary Sjögren's syndrome: a preliminary report.
    Jaskólska M; Chylińska M; Masiak A; Nowicka-Sauer K; Siemiński M; Ziętkiewicz M; Czuszyńska Z; Zdrojewski Z
    Rheumatol Int; 2020 Aug; 40(8):1267-1274. PubMed ID: 32172462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Go Ask Your Patients! PSS-QoL Reported Perception of Dryness Correlates With Lacrimal and Salivary Flow in Primary Sjögren's Syndrome.
    Lackner A; Bosch P; Zenz S; Horwath-Winter J; Rabensteiner DF; Hermann J; Graninger W; Stradner MH
    Front Med (Lausanne); 2021; 8():660580. PubMed ID: 33937295
    [No Abstract]   [Full Text] [Related]  

  • 53. The EULAR Sjögren's Syndrome Patient-Reported Index is an independent determinant of health-related utility values of Korean patients with primary Sjögren's syndrome.
    Lee J; Koh JH; Kwok SK; Park SH
    Clin Exp Rheumatol; 2016; 34(4):663-7. PubMed ID: 27050672
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Qualitative Research with Patients and Physicians to Assess Content Validity and Meaningful Change on ESSDAI and ESSPRI in Sjögren's.
    Cooper C; Wratten S; Williams-Hall R; Bookman AAM; Ndife B; Hueber W; Goswami P
    Rheumatol Ther; 2022 Dec; 9(6):1499-1515. PubMed ID: 36114443
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical features and risk factors of neurological involvement in Sjögren's syndrome.
    Ye W; Chen S; Huang X; Qin W; Zhang T; Zhu X; Zhu X; Lin C; Wang X
    BMC Neurosci; 2018 Apr; 19(1):26. PubMed ID: 29703151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of cutaneous silent period parameters in patients with primary Sjögren's syndrome with the healthy population and determination of ıts relationship with clinical parameters.
    Yolcu G; Abacar KY; Kenis-Coskun O; Nevsun-Inanc G; Karadag-Saygi E; Gunduz OH
    Rheumatol Int; 2023 Feb; 43(2):355-362. PubMed ID: 36048188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren's syndrome.
    Olsson P; Bodewes ILA; Nilsson AM; Turesson C; Jacobsson LTH; Theander E; Versnel MA; Mandl T
    Rheumatol Int; 2019 Sep; 39(9):1575-1584. PubMed ID: 31139950
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abdominal symptoms during Sjogren's syndrome: a pilot study.
    Parreau S; Jacques J; Dumonteil S; Palat S; Geyl S; Gondran G; Bezanahary H; Liozon E; Azaïs J; Colombie S; Jauberteau MO; Loustaud-Ratti V; Ly KH; Fauchais AL
    Adv Rheumatol; 2021 Jan; 61(1):5. PubMed ID: 33468262
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors that affect the number of tender points in fibromyalgia and chronic widespread pain patients who did not meet the ACR 1990 criteria for fibromyalgia: are tender points a reflection of neuropathic pain?
    Pamuk ON; Yeşil Y; Cakir N
    Semin Arthritis Rheum; 2006 Oct; 36(2):130-4. PubMed ID: 16884973
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fatigue and depression predict physician visits and work disability in women with primary Sjögren's syndrome: results from a cohort study.
    Westhoff G; Dörner T; Zink A
    Rheumatology (Oxford); 2012 Feb; 51(2):262-9. PubMed ID: 21705778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.